Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre-Emmanuel Colombo

Showing results (41-50 of 96) with videos related to

Pageof 10
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 16, 2020
Intraoperative partial irradiation for highly selected patients with breast cancer: Results of the INTRAOBS prospective studyClaire Lemanski, Celine Bourgier, Roxanna Draghici, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2017
Is post-mastectomy radiation therapy contributive in pN0-1mi breast cancer patients? Results of a French multi-centric cohortViolaine Forissier, Agnès Tallet, Monique Cohen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 25, 2020
Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trialSimone Koole, Ruby van Stein, Karolina Sikorska, et al.
International Journal of Molecular Sciences|September 28, 2023
Differential Sensitivity of Germline and Somatic <i>BRCA</i> Variants to PARP Inhibitor in High-Grade Serous Ovarian CancerJulie A Vendrell, Iulian O Ban, Isabelle Solassol, et al.
Oncotarget|September 4, 2015
Ovarian carcinoma patient derived xenografts reproduce their tumor of origin and preserve an oligoclonal structurePierre-Emmanuel Colombo, Stanislas du Manoir, Béatrice Orsett, et al.
Frontiers in Oncology|April 3, 2023
<i>BRCA1</i>-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparibCarolina Velazquez, Esin Orhan, Imene Tabet, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2010
Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of noninternalizing 125I-labeled monoclonal antibodiesVincent Boudousq, Stéphanie Ricaud, Véronique Garambois, et al.
Tumori|March 23, 2019
Tubular and mucinous breast cancer: results of a cohort of 917 patientsPauline Roux, Sophie Knight, Monique Cohen, et al.
Scientific Reports|January 27, 2021
Anti-Müllerian hormone (AMH) autocrine signaling promotes survival and proliferation of ovarian cancer cellsMaëva Chauvin, Véronique Garambois, Pierre-Emmanuel Colombo, et al.
Histopathology|May 9, 2015
Resolving quandaries: basaloid adenoid cystic carcinoma or breast cylindroma? The role of massively parallel sequencingNicola Fusco, Pierre-Emmanuel Colombo, Luciano G Martelotto, et al.
Pageof 10

Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 16, 2020
Intraoperative partial irradiation for highly selected patients with breast cancer: Results of the INTRAOBS prospective studyClaire Lemanski, Celine Bourgier, Roxanna Draghici, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2017
Is post-mastectomy radiation therapy contributive in pN0-1mi breast cancer patients? Results of a French multi-centric cohortViolaine Forissier, Agnès Tallet, Monique Cohen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 25, 2020
Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trialSimone Koole, Ruby van Stein, Karolina Sikorska, et al.
International Journal of Molecular Sciences|September 28, 2023
Differential Sensitivity of Germline and Somatic <i>BRCA</i> Variants to PARP Inhibitor in High-Grade Serous Ovarian CancerJulie A Vendrell, Iulian O Ban, Isabelle Solassol, et al.
Oncotarget|September 4, 2015
Ovarian carcinoma patient derived xenografts reproduce their tumor of origin and preserve an oligoclonal structurePierre-Emmanuel Colombo, Stanislas du Manoir, Béatrice Orsett, et al.
Frontiers in Oncology|April 3, 2023
<i>BRCA1</i>-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparibCarolina Velazquez, Esin Orhan, Imene Tabet, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2010
Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of noninternalizing 125I-labeled monoclonal antibodiesVincent Boudousq, Stéphanie Ricaud, Véronique Garambois, et al.
Tumori|March 23, 2019
Tubular and mucinous breast cancer: results of a cohort of 917 patientsPauline Roux, Sophie Knight, Monique Cohen, et al.
Scientific Reports|January 27, 2021
Anti-Müllerian hormone (AMH) autocrine signaling promotes survival and proliferation of ovarian cancer cellsMaëva Chauvin, Véronique Garambois, Pierre-Emmanuel Colombo, et al.
Histopathology|May 9, 2015
Resolving quandaries: basaloid adenoid cystic carcinoma or breast cylindroma? The role of massively parallel sequencingNicola Fusco, Pierre-Emmanuel Colombo, Luciano G Martelotto, et al.
Pageof 10